← Back to patent-cliff list
VMD-3866
Tier C — Watch / tradeVMD-3866
VM Therapeutics LLC
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：VDCCs
Indications (approved)：Nephropathy, Peripheral nervous system disorder
Regional status
US
-
EU
Phase II
2025-12-12
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of VMD-3866?
Approved indications include: Nephropathy, Peripheral nervous system disorder.
When does the VMD-3866 patent expire?
No public expiry year is available for VMD-3866 yet; this page updates once verified.
How do I get a quote for VMD-3866 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29